3,3’-diindolylmethane (DIM) and its ring-substituted halogenated analogs (ring-DIMS) induce differential mechanisms of survival and death in androgen-dependent and –independent prostate cancer cells

Genes and Cancer

Volumn 6, Issue 5-6, 2015, Pages 265-280

  Goldberg, Alexander A ^a,b   Draz, Hossam ^a,c   Montes Grajales, Diana ^d   Olivero Verbél, Jesus ^d   Safe, Stephen H ^e   Sanderson, J Thomas ^a  

^a INRS INSTITUT ARMAND FRAPPIER   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c NATIONAL RESEARCH CENTRE   (Egypt)

^d UNIVERSIDAD DE CARTAGENA   (Colombia)

^e TEXAS A AND M UNIVERSITY   (United States)

Author keywords

C42B; DU145; LNCaP; Mitochondrial function; Prostate cancer

Indexed keywords

3,3' DIINDOLYLMETHANE; 3,3' DIINDOLYLMETHANE DERIVATIVE; 4,4' DIBROMO 3,3' DIINDOLYLMETHANE; 4,4' DICHLORO 3,3' DIINDOLYLMETHANE; 7,7' DIBROMO 3,3' DIINDOLYLMETHANE; 7,7' DICHLORO 3,3' DIINDOLYLMETHANE; ACTIVATING TRANSCRIPTION FACTOR 4; CYCLOSPORIN A; INDOLE DERIVATIVE; MATRIX METALLOPROTEINASE; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; SALUBRINAL; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; AUTOPHAGY; BINDING AFFINITY; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENDOPLASMIC RETICULUM STRESS; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MITOCHONDRIAL MEMBRANE POTENTIAL; MOLECULAR DOCKING; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

EID: 84949554281     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Siegel R, Naishadham D and Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013; 63:11-30.
2. McLeod DG. Tolerability of Nonsteroidal Antiandrogens in the Treatment of Advanced Prostate Cancer. Oncologist. 1997; 2:18-27.
3. Wysowski DK, Freiman JP, Tourtelot JB and Horton ML, 3rd. Fatal and nonfatal hepatotoxicity associated with flutamide. Ann Intern Med. 1993; 118:860-864.
4. Bjeldanes LF, Kim JY, Grose KR, Bartholomew JC and Bradfield CA. Aromatic hydrocarbon responsivenessreceptoragonists generated from indole-3-carbinol in vitro and in vivo: comparisons with 2,3,7,8-tetrachlorodibenzop-dioxin. Proc Natl Acad Sci U S A. 1991; 88:9543-9547.
5. De Kruif CA, Marsman JW, Venekamp JC, Falke HE, Noordhoek J, Blaauboer BJ and Wortelboer HM. Structure elucidation of acid reaction products of indole-3-carbinol: detection in vivo and enzyme induction in vitro. Chem BiolInteract. 1991; 80:303-315.
6. Ge X, Yannai S, Rennert G, Gruener N and Fares FA. 3,3’-Diindolylmethane induces apoptosis in human cancer cells. Biochem Biophys Res Commun. 1996; 228:153-158.
7. Nachshon-Kedmi M, Fares FA and Yannai S. Therapeutic activity of 3,3’-diindolylmethane on prostate cancer in an in vivo model. Prostate. 2004; 61:153-160.
8. Heath EI, Heilbrun LK, Li J, Vaishampayan U, Harper F, Pemberton P and Sarkar FH. A phase I dose-escalation study of oral BR-DIM (BioResponse 3,3’- Diindolylmethane) in castrate-resistant, non-metastatic prostate cancer. Am J Transl Res. 2010; 2:402-411.
9. Bhuiyan MM, Li Y, Banerjee S, Ahmed F, Wang Z, AliS and Sarkar FH. Down-regulation of androgen receptor by 3,3’-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormonesensitive LNCaP and insensitive C4-2B prostate cancercells. Cancer Res. 2006; 66:10064-10072.
10. Le HT, Schaldach CM, Firestone GL and Bjeldanes LF. Plant-derived 3,3’-diindolylmethane is a strong androgen antagonist in human prostate cancer cells. J Biol Chem. 2003; 278:21136-21145.
11. Abdelbaqi K, Lack N, Guns ET, Kotha L, Safe S and Sanderson JT. Antiandrogenic and growth inhibitory effects of ring-substituted analogs of 3,3’-diindolylmethane (Ring- DIMs) in hormone-responsive LNCaP human prostate cancer cells. Prostate. 2011; 71:1401-1412.
12. Wang TT, Schoene NW, Milner JA and Kim YS. Broccoli-derived phytochemicals indole-3-carbinol and 3,3’-diindolylmethane exerts concentration-dependent pleiotropic effects on prostate cancer cells: comparison with other cancer preventive phytochemicals. Mol Carcinog. 2012; 51:244-256.
13. Chinnakannu K, Chen D, Li Y, Wang Z, Dou QP, Reddy GP and Sarkar FH. Cell cycle-dependent effects of 3,3’-diindolylmethane on proliferation and apoptosis of prostate cancer cells. J Cell Physiol. 2009; 219:94-99.
14. Gao N, Cheng S, Budhraja A, Liu EH, Chen J, Chen D, Yang Z, Luo J, Shi X and Zhang Z. 3,3’-Diindolylmethane exhibits antileukemic activity in vitro and in vivo through a Akt-dependent process. PLoS One. 2012; 7:e31783.
15. Garikapaty VP, Ashok BT, Tadi K, Mittelman A and Tiwari RK. 3,3’-Diindolylmethane downregulates pro-survival pathway in hormone independent prostate cancer. Biochem Biophys Res Commun. 2006; 340:718-725.
16. Kong D, Banerjee S, Huang W, Li Y, Wang Z, Kim HR and Sarkar FH. Mammalian target of rapamycin repression by 3,3’-diindolylmethane inhibits invasion and angiogenesis in platelet-derived growth factor-D-overexpressing PC3 cells. Cancer Res. 2008; 68:1927-1934.
17. Goldberg AA, Titorenko VI, Beach A, Abdelbaqi K, Safe S and Sanderson JT. Ring-substituted analogs of 3,3’-diindolylmethane (DIM) induce apoptosis and necrosis in androgen-dependent and -independent prostate cancer cells. Invest New Drugs. 2013.
18. Li Y, Wang Z, Kong D, Murthy S, Dou QP, Sheng S, Reddy GP and Sarkar FH. Regulation of FOXO3a/beta-catenin/ GSK-3beta signaling by 3,3’-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells. J Biol Chem. 2007; 282:21542-21550.
19. Li XJ, Park ES, Park MH and Kim SM. 3,3’-Diindolylmethane suppresses the growth of gastric cancer cells via activation of the Hippo signaling pathway. Oncol Rep. 2013; 30:2419-2426.
20. Nachshon-Kedmi M, Yannai S, Haj A and Fares FA. Indole- 3-carbinol and 3,3’-diindolylmethane induce apoptosis in human prostate cancer cells. Food Chem Toxicol. 2003; 41:745-752.
21. Abdelrahim M, Newman K, Vanderlaag K, Samudio I and Safe S. 3,3’-diindolylmethane (DIM) and its derivatives induce apoptosis in pancreatic cancer cells through endoplasmic reticulum stress-dependent upregulation of DR5. Carcinogenesis. 2006; 27:717-728.
22. Savino JA, 3rd, Evans JF, Rabinowitz D, Auborn KJ and Carter TH. Multiple, disparate roles for calcium signaling in apoptosis of human prostate and cervical cancer cells exposed to diindolylmethane. Mol Cancer Ther. 2006; 5:556-563.
23. Sun S, Han J, Ralph WM, Jr., Chandrasekaran A, Liu K, Auborn KJ and Carter TH. Endoplasmic reticulum stress as a correlate of cytotoxicity in human tumor cells exposed to diindolylmethane in vitro. Cell Stress Chaperones. 2004; 9:76-87.
24. Gong Y, Sohn H, Xue L, Firestone GL and Bjeldanes LF. 3,3’-Diindolylmethane is a novel mitochondrial H(+)- ATP synthase inhibitor that can induce p21(Cip1/Waf1) expression by induction of oxidative stress in human breast cancer cells. Cancer Res. 2006; 66:4880-4887.
25. Riby JE, Firestone GL and Bjeldanes LF. 3,3’-diindolylmethane reduces levels of HIF-1alpha and HIF-1 activity in hypoxic cultured human cancer cells. Biochem Pharmacol. 2008; 75:1858-1867.
26. Roy A, Ganguly A, BoseDasgupta S, Das BB, Pal C, Jaisankar P and Majumder HK. Mitochondria-dependent reactive oxygen species-mediated programmed cell death induced by 3,3’-diindolylmethane through inhibition of F0F1-ATP synthase in unicellular protozoan parasite Leishmania donovani. Mol Pharmacol. 2008; 74:1292-1307.
27. Kandala PK and Srivastava SK. Regulation of macroautophagy in ovarian cancer cells in vitro and in vivo by controlling glucose regulatory protein 78 and AMPK. Oncotarget. 2012; 3:435-449.
28. Wong CP, Hsu A, Buchanan A, Palomera-Sanchez Z, Beaver LM, Houseman EA, Williams DE, Dashwood RH and Ho E. Effects of sulforaphane and 3,3’-diindolylmethane on genome-wide promoter methylation in normal prostate epithelial cells and prostate cancer cells. PLoS One. 2014; 9:e86787.
29. Schneider CA, Rasband WS and Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012; 9:671-675.
30. Guha R, Howard MT, Hutchison GR, Murray-Rust P, Rzepa H, Steinbeck C, Wegner J and Willighagen EL. The Blue Obelisk-interoperability in chemical informatics. J Chem Inf Model. 2006; 46:991-998.
31. Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS and Olson AJ. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem. 2009; 30:2785-2791.
32. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN and Bourne PE. The Protein Data Bank. Nucleic Acids Res. 2000; 28:235-242.
33. Hetenyi C and van der Spoel D. Efficient docking of peptides to proteins without prior knowledge of the binding site. Protein Sci. 2002; 11:1729-1737.
34. Lim SV, Rahman MB and Tejo BA. Structure-based and ligand-based virtual screening of novel methyltransferase inhibitors of the dengue virus. BMC Bioinformatics. 2011; 12 Suppl 13:S24.
35. Trott O and Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010; 31:455-461.
36. Ranjan N, Andreasen KF, Kumar S, Hyde-Volpe D and Arya DP. Aminoglycoside binding to Oxytricha nova telomeric DNA. Biochemistry. 2010; 49:9891-9903.
37. Wolber G and Langer T. LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters. J Chem Inf Model. 2005; 45:160-169.
38. Durdagi S, Duff HJ and Noskov SY. Combined receptor and ligand-based approach to the universal pharmacophore model development for studies of drug blockade to the hERG1 pore domain. J Chem Inf Model. 2011; 51:463-474.
39. Mounir Z, Krishnamoorthy JL, Wang S, Papadopoulou B, Campbell S, Muller WJ, Hatzoglou M and Koromilas AE. Akt determines cell fate through inhibition of the PERKeIF2alpha phosphorylation pathway. Sci Signal. 2011; 4:ra62.
40. Rahman KW and Sarkar FH. Inhibition of nuclear translocation of nuclear factor-{kappa}B contributes to 3,3’-diindolylmethane-induced apoptosis in breast cancer cells. Cancer Res. 2005; 65:364-371.
41. Huang X, Chen Y, Zhang H, Ma Q, Zhang YW and Xu H. Salubrinal attenuates beta-amyloid-induced neuronal death and microglial activation by inhibition of the NF-kappaB pathway. Neurobiol Aging. 2012; 33:1007 e1009-1017.
42. Kessel D. Protection of Bcl-2 by salubrinal. Biochem Biophys Res Commun. 2006; 346:1320-1323.
43. Ouyang DY, Xu LH, He XH, Zhang YT, Zeng LH, Cai JY and Ren S. Autophagy is differentially induced in prostate cancer LNCaP, DU145 and PC-3 cells via distinct splicing profiles of ATG5. Autophagy. 2013; 9:20-32.
44. Rokhlin OW, Taghiyev AF, Bayer KU, Bumcrot D, Koteliansk VE, Glover RA and Cohen MB. Calcium/ calmodulin-dependent kinase II plays an important role in prostate cancer cell survival. Cancer Biol Ther. 2007; 6:732-742.
45. Liu Y and Templeton DM. Initiation of caspase-independent death in mouse mesangial cells by Cd2+: involvement of p38 kinase and CaMK-II. J Cell Physiol. 2008; 217:307-318.
46. Timmins JM, Ozcan L, Seimon TA, Li G, Malagelada C, Backs J, Backs T, Bassel-Duby R, Olson EN, Anderson ME and Tabas I. Calcium/calmodulin-dependent protein kinase II links ER stress with Fas and mitochondrial apoptosis pathways. J Clin Invest. 2009; 119:2925-2941.
47. Mamaeva OA, Kim J, Feng G and McDonald JM. Calcium/ calmodulin-dependent kinase II regulates notch-1 signaling in prostate cancer cells. J Cell Biochem. 2009; 106:25-32.